ARGOS - A phase IV, prospective, 18-month study to assess the effectiveness and safety of bimatoprost intracameral implant (DURYSTA) in US clinical practice
Clinical Trial Grant
Administered By
Ophthalmology, Glaucoma
Awarded By
Allergan, Inc.
Start Date
November 1, 2021
End Date
November 1, 2024
Administered By
Ophthalmology, Glaucoma
Awarded By
Allergan, Inc.
Start Date
November 1, 2021
End Date
November 1, 2024